Paying users zone. Data is hidden behind 
.
Get 1-month access to Becton, Dickinson & Co. for $17.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Becton, Dickinson & Co. (BDX)
Analysis of Solvency Ratios
Quarterly Data
Beginner level
Solvency ratios also known as long-term debt ratios measure a company’s ability to meet long-term obligations.
Solvency Ratios (Summary)
Becton, Dickinson & Co., solvency ratios (quarterly data)
Based on: 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06), 10-K (filing date: 2014-11-26), 10-Q (filing date: 2014-08-04), 10-Q (filing date: 2014-05-05), 10-Q (filing date: 2014-02-10).
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to equity ratio | A solvency ratio calculated as total debt divided by total shareholders’ equity. | Becton, Dickinson & Co.’s debt to equity ratio improved from Q2 2019 to Q3 2019 and from Q3 2019 to Q4 2019. |
| Debt to capital ratio | A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. | Becton, Dickinson & Co.’s debt to capital ratio improved from Q2 2019 to Q3 2019 and from Q3 2019 to Q4 2019. |
| Debt to assets ratio | A solvency ratio calculated as total debt divided by total assets. | Becton, Dickinson & Co.’s debt to assets ratio improved from Q2 2019 to Q3 2019 and from Q3 2019 to Q4 2019. |
| Financial leverage ratio | A solvency ratio calculated as total assets divided by total shareholders’ equity. | Becton, Dickinson & Co.’s financial leverage ratio decreased from Q2 2019 to Q3 2019 but then increased from Q3 2019 to Q4 2019 not reaching Q2 2019 level. |
| Solvency ratio | Description | The company |
|---|---|---|
| Interest coverage ratio | A solvency ratio calculated as EBIT divided by interest payments. | Becton, Dickinson & Co.’s interest coverage ratio deteriorated from Q2 2019 to Q3 2019 and from Q3 2019 to Q4 2019. |
Debt to Equity
Becton, Dickinson & Co., debt to equity calculation (quarterly data)
| Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||
| Short-term debt | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Long-term debt, excluding current portion | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total debt | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ equity | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Solvency Ratio | |||||||||||||||||||||||||
| Debt to equity1 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Benchmarks | |||||||||||||||||||||||||
| Debt to Equity, Competitors2 | |||||||||||||||||||||||||
| Boston Scientific Corp. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intuitive Surgical Inc. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Medtronic PLC | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stryker Corp. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Thermo Fisher Scientific Inc. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UnitedHealth Group Inc. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Based on: 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06), 10-K (filing date: 2014-11-26), 10-Q (filing date: 2014-08-04), 10-Q (filing date: 2014-05-05), 10-Q (filing date: 2014-02-10).
1 Q4 2019 Calculation
Debt to equity = Total debt ÷ Shareholders’ equity
= ÷ =
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to equity ratio | A solvency ratio calculated as total debt divided by total shareholders’ equity. | Becton, Dickinson & Co.’s debt to equity ratio improved from Q2 2019 to Q3 2019 and from Q3 2019 to Q4 2019. |
Debt to Capital
Becton, Dickinson & Co., debt to capital calculation (quarterly data)
| Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||
| Short-term debt | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Long-term debt, excluding current portion | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total debt | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ equity | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total capital | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Solvency Ratio | |||||||||||||||||||||||||
| Debt to capital1 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Benchmarks | |||||||||||||||||||||||||
| Debt to Capital, Competitors2 | |||||||||||||||||||||||||
| Boston Scientific Corp. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intuitive Surgical Inc. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Medtronic PLC | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stryker Corp. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Thermo Fisher Scientific Inc. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UnitedHealth Group Inc. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Based on: 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06), 10-K (filing date: 2014-11-26), 10-Q (filing date: 2014-08-04), 10-Q (filing date: 2014-05-05), 10-Q (filing date: 2014-02-10).
1 Q4 2019 Calculation
Debt to capital = Total debt ÷ Total capital
= ÷ =
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to capital ratio | A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. | Becton, Dickinson & Co.’s debt to capital ratio improved from Q2 2019 to Q3 2019 and from Q3 2019 to Q4 2019. |
Debt to Assets
Becton, Dickinson & Co., debt to assets calculation (quarterly data)
| Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||
| Short-term debt | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Long-term debt, excluding current portion | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total debt | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total assets | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Solvency Ratio | |||||||||||||||||||||||||
| Debt to assets1 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Benchmarks | |||||||||||||||||||||||||
| Debt to Assets, Competitors2 | |||||||||||||||||||||||||
| Boston Scientific Corp. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intuitive Surgical Inc. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Medtronic PLC | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stryker Corp. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Thermo Fisher Scientific Inc. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UnitedHealth Group Inc. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Based on: 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06), 10-K (filing date: 2014-11-26), 10-Q (filing date: 2014-08-04), 10-Q (filing date: 2014-05-05), 10-Q (filing date: 2014-02-10).
1 Q4 2019 Calculation
Debt to assets = Total debt ÷ Total assets
= ÷ =
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Debt to assets ratio | A solvency ratio calculated as total debt divided by total assets. | Becton, Dickinson & Co.’s debt to assets ratio improved from Q2 2019 to Q3 2019 and from Q3 2019 to Q4 2019. |
Financial Leverage
Becton, Dickinson & Co., financial leverage calculation (quarterly data)
| Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||
| Total assets | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ equity | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Solvency Ratio | |||||||||||||||||||||||||
| Financial leverage1 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Benchmarks | |||||||||||||||||||||||||
| Financial Leverage, Competitors2 | |||||||||||||||||||||||||
| Boston Scientific Corp. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intuitive Surgical Inc. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Medtronic PLC | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stryker Corp. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Thermo Fisher Scientific Inc. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UnitedHealth Group Inc. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Based on: 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06), 10-K (filing date: 2014-11-26), 10-Q (filing date: 2014-08-04), 10-Q (filing date: 2014-05-05), 10-Q (filing date: 2014-02-10).
1 Q4 2019 Calculation
Financial leverage = Total assets ÷ Shareholders’ equity
= ÷ =
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Financial leverage ratio | A solvency ratio calculated as total assets divided by total shareholders’ equity. | Becton, Dickinson & Co.’s financial leverage ratio decreased from Q2 2019 to Q3 2019 but then increased from Q3 2019 to Q4 2019 not reaching Q2 2019 level. |
Interest Coverage
Becton, Dickinson & Co., interest coverage calculation (quarterly data)
| Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||
| Net income (loss) | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Add: Income tax expense | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Add: Interest expense | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Earnings before interest and tax (EBIT) | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Solvency Ratio | |||||||||||||||||||||||||
| Interest coverage1 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Benchmarks | |||||||||||||||||||||||||
| Interest Coverage, Competitors2 | |||||||||||||||||||||||||
| Boston Scientific Corp. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Medtronic PLC | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UnitedHealth Group Inc. | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Based on: 10-K (filing date: 2019-11-27), 10-Q (filing date: 2019-08-06), 10-Q (filing date: 2019-05-09), 10-Q (filing date: 2019-02-05), 10-K (filing date: 2018-11-21), 10-Q (filing date: 2018-08-02), 10-Q (filing date: 2018-05-03), 10-Q (filing date: 2018-02-06), 10-K (filing date: 2017-11-22), 10-Q (filing date: 2017-08-03), 10-Q (filing date: 2017-05-02), 10-Q (filing date: 2017-02-02), 10-K (filing date: 2016-11-23), 10-Q (filing date: 2016-08-04), 10-Q (filing date: 2016-05-06), 10-Q (filing date: 2016-02-05), 10-K (filing date: 2015-11-25), 10-Q (filing date: 2015-08-06), 10-Q (filing date: 2015-05-08), 10-Q (filing date: 2015-02-06), 10-K (filing date: 2014-11-26), 10-Q (filing date: 2014-08-04), 10-Q (filing date: 2014-05-05), 10-Q (filing date: 2014-02-10).
1 Q4 2019 Calculation
Interest coverage
= (EBITQ4 2019
+ EBITQ3 2019
+ EBITQ2 2019
+ EBITQ1 2019)
÷ (Interest expenseQ4 2019
+ Interest expenseQ3 2019
+ Interest expenseQ2 2019
+ Interest expenseQ1 2019)
= ( + + + )
÷ ( + + + )
=
2 Click competitor name to see calculations.
| Solvency ratio | Description | The company |
|---|---|---|
| Interest coverage ratio | A solvency ratio calculated as EBIT divided by interest payments. | Becton, Dickinson & Co.’s interest coverage ratio deteriorated from Q2 2019 to Q3 2019 and from Q3 2019 to Q4 2019. |